Metraipolis › archive › dc_de36d379664f

90Y-DOTA-biotin — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/90Y-DOTA-biotin
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-06T21:46:00.929Z
SHA-256 of the archived text
add26a45eddbbd5eeb373dda53c129ec1f731a08bdeda4540fd30317fd4b999d
Stable URL of this page
https://metraipolis.com/documento/dc_de36d379664f

How to cite

90Y-DOTA-biotin — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/90Y-DOTA-biotin (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_de36d379664f (Metraipolis archive dc_de36d379664f, sha256 add26a45eddbbd5eeb373dda53c129ec1f731a08bdeda4540fd30317fd4b999d)
BibTeX
@misc{dcde36d379664f,
  title = {90Y-DOTA-biotin — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/90Y-DOTA-biotin},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_de36d379664f; sha256 add26a45eddbbd5eeb373dda53c129ec1f731a08bdeda4540fd30317fd4b999d},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/90Y-DOTA-biotin. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

90Y-DOTA-biotin consists of a radioactive substance (yttrium-90) complexed by a chelating agent (DOTA), which in turn is attached to the vitamin biotin via a chemical linker. It is used experimentally in pretargeted radioimmunotherapy. Animal studies have been conducted as well as clinical studies in humans. In pretargeted radioimmunotherapy, two or three medications are applied in succession. At first, an antibody-drug conjugate is administered, which consists of a monoclonal antibody designed to target the tumour, and a chemical marker which in the case of DOTA-biotin therapy is one of the proteins avidin and streptavidin. After a time of typically one or two days to let the antibody accumulate in the tumour, a clearing agent may be given to eliminate residues of antibody that are still circulating in the bloodstream; this is especially done in humans. After a further waiting time, the radiotherapy (90Y-DOTA-biotin) is administered. Due to the high affinity of biotin to avidin and streptavidin, the radiotherapy accumulates where the antibody is, namely in the tumour, where it delivers its radioactivity.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «90Y-DOTA-biotin» — https://en.wikipedia.org/wiki/90Y-DOTA-biotin
Wikidata Q4645623: «another substance used in cancer treatment» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q4645623
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/90Y-DOTA-biotin?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1171078113, consultata il 2026-11-06T21:40:53.396Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 84b23f4e6bb9a4fb2ab9f2b39c31d5520b7599fb17d3ba664b754d5c583f3acf